| Ident. | Authors (with country if any) | Title |
|---|
| 000088 (2011) |
Lynn Rochester [Royaume-Uni] ; Katherine Baker [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; David Burn [Royaume-Uni] | Targeting dopa‐sensitive and dopa‐resistant gait dysfunction in Parkinson's disease: Selective responses to internal and external cues |
| 000093 (2011) |
Stefan T. Schwarz [Royaume-Uni] ; Timothy Rittman [Royaume-Uni] ; Vamsi Gontu [Royaume-Uni] ; Paul S. Morgan [Royaume-Uni] ; Nin Bajaj [Royaume-Uni] ; Dorothee P. Auer [Royaume-Uni] | T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease |
| 000095 (2011) |
Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada] | Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease |
| 000098 (2011) |
Marwan I. Hariz [Royaume-Uni] | Surgical probings into the basal ganglia: Hemorrhage and hardware‐related risks, and costs of microelectrode recording |
| 000109 (2011) |
Philip A. Starr [États-Unis] ; Paul Bejjani [Liban] ; Andres M. Lozano [Canada] ; Leo Verhagen Metman [États-Unis] ; And Marwan I. Hariz [Royaume-Uni] | Stereotactic techniques and perioperative management of DBS in dystonia |
| 000115 (2011) |
Carl E. Clarke [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops? |
| 000129 (2011) |
Claudia Trenkwalder [Allemagne] ; Bryan Kies [Afrique du Sud] ; Monika Rudzinska [Pologne] ; Jennifer Fine [Afrique du Sud] ; Janos Nikl [Hongrie] ; Krystyna Honczarenko [Pologne] ; Peter Dioszeghy [Hongrie] ; Dennis Hill [États-Unis] ; Tim Anderson [Nouvelle-Zélande] ; Vilho Myllyla [Finlande] ; Jan Kassubek [Allemagne] ; Malcolm Steiger [Royaume-Uni] ; Marco Zucconi [Italie] ; Eduardo Tolosa [Espagne] ; Werner Poewe [Autriche] ; Erwin Surmann [Allemagne] ; John Whitesides [États-Unis] ; Babak Boroojerdi [Allemagne] ; Kallol Ray Chaudhuri [Royaume-Uni] ; the RECOVER Study Group [Allemagne, Afrique du Sud, Pologne, Hongrie, États-Unis, Nouvelle-Zélande, Finlande, Royaume-Uni, Italie, Espagne, Autriche] | Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER) |
| 000148 (2011) |
D. Aarsland [Norvège] ; L. Marsh [États-Unis] ; A. Schrag [Royaume-Uni] | Reply: Neuropsychiatric symptoms in Parkinson's disease |
| 000153 (2011) |
Jan S Tochl [Royaume-Uni] ; Jir Klempír [République tchèque] ; Jan Roth [République tchèque] | Reply: CAG repeat size in the normal HTT allele and age of onset in Huntington's disease |
| 000163 (2011) |
Susanne A. Schneider [Allemagne] ; Kailash P. Bhatia [Royaume-Uni] | Recognition of faciobrachial dystonic seizures allowing early intervention with prevention of development of full‐blown limbic encephalitis |
| 000167 (2011) |
Carl Fernandes [Royaume-Uni] ; Prashanth Reddy [Royaume-Uni] ; Belinda Kessel [Royaume-Uni] | Rasagiline‐induced serotonin syndrome |
| 000169 (2011) |
Kurt A. Jellinger [Autriche] ; Johannes Attems [Royaume-Uni] | Rapidly progressing diffuse Lewy body disease |
| 000174 (2011) |
M. Duleeka W. Knipe [Royaume-Uni] ; Mirdhu M. Wickremaratchi [Royaume-Uni] ; Emma Wyatt-Haines [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] | Quality of life in young‐ compared with late‐onset Parkinson's disease |
| 000178 (2011) |
Sarah Kranick [États-Unis] ; Vindhya Ekanayake [États-Unis] ; Valeria Martinez [États-Unis] ; Rezvan Ameli [États-Unis] ; Mark Hallett [États-Unis] ; Valerie Voon [États-Unis, Royaume-Uni] | Psychopathology and psychogenic movement disorders |
| 000179 (2011) |
Anthony E. Lang [Canada] ; Valerie Voon [Royaume-Uni] | Psychogenic movement disorders: Past developments, current status, and future directions |
| 000180 (2011) |
Kathryn J. Peall [Royaume-Uni] ; Adrian J. Waite [Royaume-Uni] ; Derek J. Blake [Royaume-Uni] ; Mike J. Owen [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] | Psychiatric disorders, myoclonus dystonia, and the epsilon‐sarcoglycan gene: A systematic review |
| 000184 (2011) |
Giovanni Fabbrini [Italie] ; Marcello Merello [Argentine] ; Andrew H. Evans [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Janice Holton [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] | Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: Clinicopathological case |
| 000195 (2011) |
Francisco Cardoso [Brésil] ; John Hodges [Australie] ; Andrew H. Evans [Australie] ; Tamas Revesz [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] | Postural instability, frontotemporal dementia, and ophthalmoplegia: Clinicopathological case |
| 000200 (2011) |
Gun-Marie Hariz [Suède] ; Patricia Limousin [Royaume-Uni] ; Stephen Tisch [Australie] ; Marjan Jahanshahi [Royaume-Uni] ; Anncristine Fjellman-Wiklund [Suède] | Patients' perceptions of life shift after deep brain stimulation for primary dystonia—A qualitative study |
| 000202 (2011) |
Phillip Fletcher [Royaume-Uni] ; Alison Leake [Royaume-Uni] ; Marie-Helene Marion [Royaume-Uni] | Patients with Parkinson's disease dementia stay in the hospital twice as long as those without dementia |
| 000206 (2011) |
Atbin Djamshidian [Royaume-Uni] ; Francisco Cardoso [Brésil] ; Donald Grosset [Royaume-Uni] ; Henrietta Bowden-Jones [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Pathological gambling in Parkinson's disease—a review of the literature |
